Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001598838 | SCV001827408 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807435 | SCV002054587 | benign | Myoclonus, familial, 2 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807432 | SCV002054588 | benign | Cognitive impairment with or without cerebellar ataxia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807433 | SCV002054589 | benign | Developmental and epileptic encephalopathy, 13 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807434 | SCV002054590 | benign | Seizures, benign familial infantile, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594374 | SCV005087759 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 98% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 91. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001598838 | SCV005228887 | benign | not provided | criteria provided, single submitter | not provided |